Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC

Topics of Professional Interest:
  • Pneumocystis jiroveci pneumonia
  • Prophylaxis of opportunistic infections
  • Management of opportunistic infections
  • Hepatitis C
Committees and Organizations:
  • American Society for Clinical Investigation
  • Association of American Physicians
Honors and Awards:
  • Past President, Infectious Disease Society of America
  • ASCI
  • AAP
Education:
  • Dartmouth University, AB (1968)
  • Cornell University, MD (1972)
Selected Publications:

High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC.

Levy ME, Greenberg AE, Hart R, Powers Happ L, Hadigan C, Castel A; DC Cohort Executive Committee.

HIV Med. 2017 May 15. doi: 10.1111/hiv.12516. [Epub ahead of print]

PMID:
 
28503912
2.

Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care - Washington, DC.

Castel AD, Kalmin MM, Hart RL, Young HA, Hays H, Benator D, Kumar P, Elion R, Parenti D, Ruiz ME, Wood A, D'Angelo L, Rakhmanina N, Rana S, Bryant M, Hebou A, Fernández R, Abbott S, Peterson J, Wood K, Subramanian T, Binkley J, Happ LP, Kharfen M, Masur H, Greenberg AE.

AIDS Care. 2016 Nov;28(11):1355-64. doi: 10.1080/09540121.2016.1189496. Epub 2016 Jun 13.

PMID:
 
27297952
3.

Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial.

Meissner EG, McLaughlin M, Matthews L, Gharib AM, Wood BJ, Levy E, Sinkus R, Virtaneva K, Sturdevant D, Martens C, Porcella SF, Goodman ZD, Kanwar B, Myers RP, Subramanian M, Hadigan C, Masur H, Kleiner DE, Heller T, Kottilil S, Kovacs JA, Morse CG.

Liver Int. 2016 Dec;36(12):1783-1792. doi: 10.1111/liv.13177. Epub 2016 Jul 6.

PMID:
 
27232579
4.

The pharmacist: An indispensable partner in HIV care.

Pau AK, Lane HC, Masur H.

Am J Health Syst Pharm. 2016 Apr 1;73(7):431. doi: 10.2146/ajhp160077. No abstract available. 

PMID:
 
27001981
5.

Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus Infection.

Siegel M, Masur H, Kovacs J.

Semin Respir Crit Care Med. 2016 Apr;37(2):243-56. doi: 10.1055/s-0036-1579556. Epub 2016 Mar 14. Review.

PMID:
 
26974301
6.

Critical Care Medicine After the 2014-2015 Ebola Outbreak: Are We Ready If It Happens Again?

Chertow DS, Palmore TN, Masur H.

Crit Care Med. 2016 Mar;44(3):457-9. doi: 10.1097/CCM.0000000000001590. No abstract available. 

PMID:
 
26901541
7.

Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.

Meissner EG, Kohli A, Virtaneva K, Sturdevant D, Martens C, Porcella SF, McHutchison JG, Masur H, Kottilil S.

J Viral Hepat. 2016 Jul;23(7):496-505. doi: 10.1111/jvh.12510. Epub 2016 Feb 3.

8.

Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir.

Townsend K, Petersen T, Gordon LA, Kohli A, Nelson A, Seamon C, Gross C, Tang L, Osinusi A, Polis MA, Masur H, Kottilil S.

AIDS. 2016 Jan;30(2):261-6. doi: 10.1097/QAD.0000000000000903.

PMID:
 
26691547
9.

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study.

Petersen T, Townsend K, Gordon LA, Sidharthan S, Silk R, Nelson A, Gross C, Calderón M, Proschan M, Osinusi A, Polis MA, Masur H, Kottilil S, Kohli A.

Hepatol Int. 2016 Mar;10(2):310-9. doi: 10.1007/s12072-015-9680-7. Epub 2015 Nov 26.

10.

Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.

Kohli A, Kattakuzhy S, Sidharthan S, Nelson A, McLaughlin M, Seamon C, Wilson E, Meissner EG, Sims Z, Silk R, Gross C, Akoth E, Tang L, Price A, Jolley TA, Emmanuel B, Proschan M, Teferi G, Chavez J, Abbott S, Osinusi A, Mo H, Polis MA, Masur H, Kottilil S.

Ann Intern Med. 2015 Dec 15;163(12):899-907. doi: 10.7326/M15-0642. Epub 2015 Nov 24.

PMID:
 
26595450
11.

Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.

Townsend K, Meissner EG, Sidharthan S, Sampson M, Remaley AT, Tang L, Kohli A, Osinusi A, Masur H, Kottilil S.

AIDS Res Hum Retroviruses. 2016 May;32(5):456-62. doi: 10.1089/AID.2015.0170. Epub 2015 Dec 15.

12.

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.

Wilson EM, Kattakuzhy S, Sidharthan S, Sims Z, Tang L, McLaughlin M, Price A, Nelson A, Silk R, Gross C, Akoth E, Mo H, Subramanian GM, Pang PS, McHutchison JG, Osinusi A, Masur H, Kohli A, Kottilil S.

Clin Infect Dis. 2016 Feb 1;62(3):280-288. doi: 10.1093/cid/civ874. Epub 2015 Oct 31.

13.

HIV-Related Opportunistic Infections Are Still Relevant in 2015.

Masur H.

Top Antivir Med. 2015 Aug-Sep;23(3):116-9.

PMID:
 
26518395